| NDC Code | 51352-189-73 |
|---|
| Package Description | 3 BOTTLE in 1 CASE (51352-189-73) / 30 mL in 1 BOTTLE |
|---|
| Product NDC | 51352-189 |
|---|
| Product Type Name | HUMAN OTC DRUG |
|---|
| Proprietary Name | Pancold A |
|---|
| Non-Proprietary Name | Acetaminophen, Guaifenesin, Pentoxyverine Citrate, Phenylpehrine Hydcrochloride, Chlorpheniramine Maleate, Caffeine Anhydrous |
|---|
| Dosage Form | LIQUID |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20230701 |
|---|
| End Marketing Date | 20280604 |
|---|
| Marketing Category Name | OTC MONOGRAPH DRUG |
|---|
| Application Number | M012 |
|---|
| Manufacturer | DONGWHA PHARM. CO. LTD. |
|---|
| Substance Name | ACETAMINOPHEN; CAFFEINE; CHLORPHENIRAMINE MALEATE; GUAIFENESIN; PENTOXYVERINE CITRATE; PHENYLEPHRINE HYDROCHLORIDE |
|---|
| Strength | 300; 30; 2.5; 80; 15; 10 |
|---|
| Strength Unit | mg/30mL; mg/30mL; mg/30mL; mg/30mL; mg/30mL; mg/30mL |
|---|
| Pharmacy Classes | Adrenergic alpha1-Agonists [MoA], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Increased Respiratory Secretions [PE], Methylxanthine [EPC], Xanthines [CS], alpha-1 Adrenergic Agonist [EPC] |
|---|